These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33273509)

  • 21. Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target.
    DurdaĞi S
    Turk J Biol; 2020; 44(3):185-191. PubMed ID: 32595355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Repurposing Approaches: Existing Leads For Novel Threats And Drug Targets.
    Usha T; Middha SK; Kukanur AA; Shravani RV; Anupama MN; Harshitha N; Rahamath A; Kukanuri SA; Goyal AK
    Curr Protein Pept Sci; 2020 Sep; ():. PubMed ID: 32957901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Repurposing from an Academic Perspective.
    Oprea TI; Bauman JE; Bologa CG; Buranda T; Chigaev A; Edwards BS; Jarvik JW; Gresham HD; Haynes MK; Hjelle B; Hromas R; Hudson L; Mackenzie DA; Muller CY; Reed JC; Simons PC; Smagley Y; Strouse J; Surviladze Z; Thompson T; Ursu O; Waller A; Wandinger-Ness A; Winter SS; Wu Y; Young SM; Larson RS; Willman C; Sklar LA
    Drug Discov Today Ther Strateg; 2011; 8(3-4):61-69. PubMed ID: 22368688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy.
    Zali H; Golchin A; Farahani M; Yazdani M; Ranjbar MM; Dabbagh A
    Iran J Pharm Res; 2019; 18(3):1639-1647. PubMed ID: 32641971
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Gurung AB; Ali MA; Lee J; Abul Farah M; Al-Anazi KM
    Saudi J Biol Sci; 2020 Oct; 27(10):2674-2682. PubMed ID: 32837219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DeCoST: A New Approach in Drug Repurposing From Control System Theory.
    Nguyen TM; Muhammad SA; Ibrahim S; Ma L; Guo J; Bai B; Zeng B
    Front Pharmacol; 2018; 9():583. PubMed ID: 29922160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure investigation, enrichment analysis and structure-based repurposing of FDA-approved drugs as inhibitors of BET-BRD4.
    Wakchaure P; Velayutham R; Roy KK
    J Biomol Struct Dyn; 2019 Aug; 37(12):3048-3057. PubMed ID: 30079805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing.
    de Anda-Jáuregui G; Guo K; McGregor BA; Hur J
    Front Physiol; 2018; 9():151. PubMed ID: 29545755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatics approach to prioritize known drugs towards repurposing for tuberculosis.
    Brindha S; Vincent S; Velmurugan D; Ananthakrishnan D; Sundaramurthi JC; Gnanadoss JJ
    Med Hypotheses; 2017 Jun; 103():39-45. PubMed ID: 28571806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A tool to utilize adverse effect profiles to identify brain-active medications for repurposing.
    McCoy TH; Perlis RH
    Int J Neuropsychopharmacol; 2015 Feb; 18(3):. PubMed ID: 25673184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs.
    Coussens NP; Braisted JC; Peryea T; Sittampalam GS; Simeonov A; Hall MD
    Pharmacol Rev; 2017 Oct; 69(4):479-496. PubMed ID: 28931623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs.
    Mao F; Ni W; Xu X; Wang H; Wang J; Ji M; Li J
    Molecules; 2016 Jan; 21(1):75. PubMed ID: 26771590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel computational approach for drug repurposing using systems biology.
    Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
    Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rings in Clinical Trials and Drugs: Present and Future.
    Shearer J; Castro JL; Lawson ADG; MacCoss M; Taylor RD
    J Med Chem; 2022 Jul; 65(13):8699-8712. PubMed ID: 35730680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The first wide-scale drug repurposing screen using the Prestwick Chemical Library (1200 bioactive molecules) against Neisseria gonorrhoeae identifies high in vitro activity of auranofin and many additional drugs.
    Foerster S; Gustafsson TN; Brochado AR; Desilvestro V; Typas A; Unemo M
    APMIS; 2020 Mar; 128(3):242-250. PubMed ID: 31811739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy.
    Sidarovich V; De Mariano M; Aveic S; Pancher M; Adami V; Gatto P; Pizzini S; Pasini L; Croce M; Parodi F; Cimmino F; Avitabile M; Emionite L; Cilli M; Ferrini S; Pagano A; Capasso M; Quattrone A; Tonini GP; Longo L
    Mol Cancer Ther; 2018 Jul; 17(7):1405-1415. PubMed ID: 29695637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study.
    Chittepu VCSR; Kalhotra P; Osorio-Gallardo T; Gallardo-Velázquez T; Osorio-Revilla G
    Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31108878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular property diagnostic suite for diabetes mellitus (MPDS
    Gaur AS; Nagamani S; Tanneeru K; Druzhilovskiy D; Rudik A; Poroikov V; Narahari Sastry G
    J Biomed Inform; 2018 Sep; 85():114-125. PubMed ID: 30092360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An oncoinformatics study to predict the inhibitory potential of recent FDA-approved anti-cancer drugs against human Polo-like kinase 1 enzyme: a step towards dual-target cancer medication.
    Rizvi SMD; Alshammari AAA; Almawkaa WA; Ahmed ABF; Katamesh A; Alafnan A; Almutairi TJ; Alshammari RF
    3 Biotech; 2019 Mar; 9(3):70. PubMed ID: 30800581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.